CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents ($160,967 and $171,047 restricted at December 31, 2018 and September 30, 2019, respectively)	$ 376,703	$ 272,308
Accounts receivable, net	812,741	756,059
Short-term investments ($363,840 and $322,515 restricted at December 31, 2018 and September 30, 2019, respectively)	336,057	382,582
Pharmaceutical inventory	48,373	40,818
Other current assets ($43,401 and $42,161 restricted at December 31, 2018 and September 30, 2019, respectively)	87,098	95,400
Total Current Assets	1,660,972	1,547,167
Property and equipment, net	141,506	150,748
Long-term investments ($2,854 and $6,484 restricted at December 31, 2018 and September 30, 2019, respectively)	7,606	3,161
Deferred income taxes	2,618	3,411
Other long-term assets	129,086	24,530
Goodwill	1,018,156	1,018,156
Other intangible assets, net	181,777	231,883
Total Assets	3,141,721	2,979,056
Current Liabilities:
Accounts payable	92,362	72,077
Accrued liabilities	307,210	231,356
Short-term contingent consideration	123	8,000
Medical claims payable	430,345	393,547
Other medical liabilities	144,838	169,639
Current debt, finance lease and deferred financing obligations	3,546	24,274
Total Current Liabilities	978,424	898,893
Long-term debt, finance lease and deferred financing obligations	695,164	728,608
Deferred income taxes	15,088	11,167
Tax contingencies	16,228	16,478
Long-term contingent consideration		2,124
Deferred credits and other long-term liabilities	74,345	36,483
Total Liabilities	1,779,249	1,693,753
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share: Authorized-10,000 shares at December 31, 2018 and September 30, 2019-Issued and outstanding-none
Common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2018 and September 30, 2019-Issued and outstanding-53,536 and 23,935 shares at December 31, 2018, respectively, and 54,131 and 24,469 shares at September 30, 2019, respectively	541	535
Other Stockholders' Equity:
Additional paid-in capital	1,371,718	1,326,645
Retained earnings	1,454,623	1,419,449
Accumulated other comprehensive (loss) income	317	(324)
Treasury stock, at cost, 29,601 and 29,662 shares at December 31, 2018 and September 30, 2019, respectively	(1,464,727)	(1,461,002)
Total Stockholders' Equity	1,362,472	1,285,303
Total Liabilities and Stockholders' Equity	$ 3,141,721	$ 2,979,056